In this study, we first identified that AF9 is a natural suppressor of breast cancer cell invasion and migration by using siRNAs targeting 591 ERF-coding genes, and a series of in vitro experiments confirmed this finding. The gene discussed is MLLT3; the disease is breast carcinoma.